Author: healthprofessionalradio

Dr. Shalini Singh, MD, Chief Medical Partner Oncology Network currently serving on the Clinical Development and Medical Affairs leadership team at Roche Diagnostics Solutions discusses the FDA approval of a new indication for Roche’s PATHWAY anti-HER2 (4B5) test to identify metastatic breast cancer patients with low HER2 expression for whom recently FDA approved ENHERTU ® may be considered as a targeted treatment.

Dr. Paul Weinberg, MD, who is now retired discusses his new book “ER DOCTOR: Tales Of An Emergency Room Doctor” where he provides an inside look at what it’s like to work in the ER.

Returning guest, Dr. Derek Wallace, MBBS, Vice President and Global Dengue Program Head at Takeda discusses the news that Takeda’s dengue vaccine candidate, TAK-003, was recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for the prevention of dengue disease caused by any serotype in individuals four years of age and older in Europe and in dengue-endemic countries which participated in the EU-M4all procedure. The news follows the vaccine’s first approval in Indonesia.

Robert Hoffman, President and CEO at Kintara Therapeutics, a company dedicated to the development of unique anti-cancer therapeutics discusses VAL-083, a “first-in-class”, small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including central nervous system (Glioblastoma Multiforme), ovarian and other solid tumors (e.g., non-small cell lung cancer, bladder cancer, head and neck) in U.S. clinical trials.

Returning guest, Dr. Craig Eagle, Chief Medical Officer of Guardant Health discusses clinical trial results on colonoscopy effectiveness and why blood-based tests can offer more accessible and convenient (but still effective) screening options.

Zack Irani, CEO of Biomerica, a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products, discusses tools to make at-home screenings for diseases like breast cancer, colon cancer, etc. simple and easy. He talks about the new technology that’s available, new screening guidelines, and why simple at-home tests and tools can help change the way diseases are managed. He also talks about new diagnostic guided therapies, such as InFoods IBS, which is designed to allow physicians to identify patient-specific foods that when removed, may alleviate or improve an individual’s IBS symptoms.

Dr. Joanne Armstrong, MD, MPH, Vice President and Chief Medical Officer, Women’s Health and Genomics at CVS Health discusses the company’s commitment to support women as they face unique health challenges, in addition to often placing other’s needs before their own.

Returning guest, Dr. Harvey Kaufman,​ MD, FCAP,​ Senior Medical Director, Medical Informatics at Quest Diagnostics, the world’s leading provider of diagnostic information services, discusses a new Quest Diagnostics Health Trends study, published in the Journal of Clinical Oncology, which shows that diagnosis of the two most common cancers – breast and prostate – remains down from pre-pandemic levels (17% and 11% respectively). This suggests people are still delaying preventative care, missing annual screenings, and could be living with unknown cancers, potentially leading to diagnosis at more advanced stages of the disease and higher rates of morbidity and death.

Kelly Heger, whose daughter has Aromatic L-amino Acid Decarboxylase deficiency or AADC deficiency, a rare and fatal genetic disorder, shares her story of getting medical training to care for her daughter and learning to navigate the medical system to get her daughter the care that she needed. Kelly’s daughter is now 26 years old and Kelly advocates for and connects patients and caregivers around the world through an organization she founded, the AADC Family Network. She is joined by Dr. Irina Anselm, child neurologist at Boston Children’s Hospital, who provides more information about AADC deficiency including how parents can recognize the signs and symptoms.

Dr. Grayson Armstrong, MD, MPH, Director, Ophthalmology Emergency Service at Massachusetts Eye and Ear and Harvard Medical School Instructor in Ophthalmology and Associate Director of Medical Student Education discusses his study on Optimizing Telemedicine and AI for Eye Care that was presented at the 2022 American Academy of Ophthalmology (AAO) Annual Meeting.